Oncologists have more innovative methods for treating breast cancer than ever before. In part one of this two-part series, Adam Rutherford and guests explore the hurdles and successes researchers face as they work to develop new, targeted therapies for breast cancer.
- Martha Carlson, Breast Cancer Advocate & Writer
- Dr. Edith Mitchell, Medical Oncologist, Thomas Jefferson University
- Jeff Settleman, Chief Scientific Officer, Pfizer Oncology